MS Patients and Healthcare Providers Report Success of MSdialog App in Tracking Disease

Patricia Silva, PhD avatar

by Patricia Silva, PhD |

Share this article:

Share article via email

An international research team recently reported that the web-based MSdialog appĀ is being adopted by bothĀ multiple sclerosis (MS) patients and healthcare providers. The study is entitled ā€œPatient and Physician Perspectives on MSdialog, an Electronic PRO Diary in Multiple Sclerosisā€ and was published in the journal The Patient – Patient-Centered Outcomes Research.

Merck SeronoĀ recently launched a web- and mobile-based software system called MSdialog, seeking to provideĀ MS patients with more control over the management of their disease. The MSdialog appĀ allows patients to track theirĀ personal health record, where individuals complete a periodic health questionnaire and can report on how MS impacts their life. The application also allows healthcare providers to monitor the patientā€™s treatment, adherence, clinical outcomes, and general health status.

In the study, the research team surveyed the opinion of 76 MS patient and 132 healthcare professionals (92 neurologists and 40 MS nurses) onĀ the benefits of the MSdialog application. In addition, 39 MS patients participated in a training teleconference and underwent a 6-week pilot study to assess MSdialog usability through weekly health reports, two usability surveys (at weeks 3 and 6), and a follow-up telephone interview.

Researchers found that the benefits of MSdialog that were most helpful forĀ MS patients were the abilityĀ to share information with healthcare providers and to report clinical outcomes. Most patients reported that the application ā€œhelps me remember what to mention to my doctor.ā€ Healthcare providers, on the other hand, were found to be highly motivated by the data provided by the application in terms of patient-reported outcomes and treatment adherence. Concerning the pilot study, 87% of the MS patients enrolled notedĀ that the completion of patient-reported outcomes via the MSdialog fitĀ ā€œfairly wellā€ to ā€œextremely wellā€ into their weekly routine. At week 6, at the end of the trial, 77% of the MS patients were ā€œvery satisfiedā€ or ā€œextremely satisfiedā€ with their MSdialog experience, 82% reported that the application was better than other health tracking methods previously used, and 95% would recommend the use of the application.

The team concluded that the MSdialog application is user-friendly and superior to other methods of tracking patient health. The ability of the MSdialog to offer valuable information to healthcare providers allows for potential improvement in patient-physician communication and engagement in the management of the disease.